Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2021

Mar 3, 2021

29933_dirs_2021-03-03_519aa1b4-2b0e-4e3d-ac6c-631c155bd332.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01

Reporting Person: MCCARTHY GLORIA M (EVP & Chief Administrative Off)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Stock F 11971 $311.48 Disposed 30128 Direct
2021-03-01 Common Stock A 2810 Acquired 32938 Direct
2021-03-01 Common Stock A 23222 Acquired 56160 Direct
2021-03-02 Common Stock F 536 $311.66 Disposed 55624 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Employee Stock Option (Right to Buy) $311.48 A 11533 Acquired 2031-03-01 Common Stock (11533.0) Direct

Footnotes

F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F2: Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024.

F3: Represents performance based restricted share units. Restrictions lapse on 3/1/2021.

F4: The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.